Skip To Main Content
Yinchen Shen on Muck Rack

Yinchen Shen

As seen in: BMJ Open Respiratory Research, Frontiers, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinchen

Contact Yinchen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Persistent vision loss of eyes lost to follow-up with diabetic macular edema receiving intravitreal anti-vascular endothelial growth factor therapy

|
By Chuandi Zhou, Yinchen Shen, Shu Q. Li
| ophthalmologyscience.org
Keywords Diabetic macular edema Anti-vascular endothelial growth factor therapy Lost to follow-up Cohort study Persistent vision loss Introduction Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults.1,2 Diabetic macular edema (DME) causes substantial vision loss in DR.3 Intravitreal injection of anti-vascular endothelial growth factor (VEGF) has revolutionized the primary care of DME and optimized visual outcomes.
Open in Who Shared Issue with article?

Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma

|
By Haijiao Lu, Jialin Qian, Yinchen Shen, Tianqing Chu
| BMJ Open Respiratory Research Verified
Discussion The TME is a complex and dynamic evolving ecosystem during the initiation, development and metastasis of tumour.
Open in Who Shared Issue with article?

Frontiers | Lineage tracing for multiple lung cancer by spatiotemporal heterogeneity using a multi-omics analysis method integrating genomic, transcriptomic, and immune-related features

|
By Tao Jiang, Yi Xiang, Yinchen Shen, Yan Xu
| Frontiers
1 Introduction Up to 20% of patients in screening populations are diagnosed with multiple lung cancer with synchronous or metachronous lung tumors, compared to a previous estimation that only 0.8%–4% of patients had multiple lesions (1). The identification of multiple pulmonary nodules raises a crucial clinical issue of whether multiple pulmonary nodules represent intrapulmonary metastasis (IPM) with a common origin or multiple primary lung cancer (MPLC) with independent lineages.
Open in Who Shared Issue with article?
See all 4 articles